Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21118657 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: N-acetylcysteine (NAC);   Drug: Inactive placebo capsule

Indicates status has not been verified in more than two years